Tokio Marine Asset Management Co. Ltd. grew its holdings in shares of The Cigna Group (NYSE:CI – Free Report) by 3.9% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 7,637 shares of the health services provider’s stock after purchasing an additional 288 shares during the period. Tokio Marine Asset Management Co. Ltd.’s holdings in The Cigna Group were worth $2,646,000 at the end of the most recent reporting period.
Several other hedge funds also recently made changes to their positions in CI. Vanguard Group Inc. grew its holdings in shares of The Cigna Group by 8.1% in the 1st quarter. Vanguard Group Inc. now owns 26,793,138 shares of the health services provider’s stock worth $9,731,000,000 after acquiring an additional 2,017,333 shares during the last quarter. Price T Rowe Associates Inc. MD boosted its position in The Cigna Group by 6.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 14,341,233 shares of the health services provider’s stock worth $5,208,593,000 after acquiring an additional 867,180 shares during the period. Dimensional Fund Advisors LP lifted its position in shares of The Cigna Group by 6.1% in the second quarter. Dimensional Fund Advisors LP now owns 2,628,807 shares of the health services provider’s stock worth $869,078,000 after purchasing an additional 150,765 shares in the last quarter. Ameriprise Financial Inc. boosted its holdings in shares of The Cigna Group by 23.4% during the second quarter. Ameriprise Financial Inc. now owns 2,138,193 shares of the health services provider’s stock worth $706,822,000 after purchasing an additional 405,694 shares during the period. Finally, AQR Capital Management LLC grew its position in The Cigna Group by 63.4% during the second quarter. AQR Capital Management LLC now owns 1,547,245 shares of the health services provider’s stock valued at $510,467,000 after purchasing an additional 600,215 shares in the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.
Insider Activity at The Cigna Group
In other news, Director William J. Delaney III sold 2,691 shares of the firm’s stock in a transaction that occurred on Monday, August 19th. The shares were sold at an average price of $342.68, for a total transaction of $922,151.88. Following the completion of the sale, the director now owns 17,539 shares of the company’s stock, valued at approximately $6,010,264.52. This trade represents a 13.30 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 0.60% of the stock is owned by insiders.
The Cigna Group Stock Down 2.5 %
The Cigna Group (NYSE:CI – Get Free Report) last issued its quarterly earnings results on Thursday, October 31st. The health services provider reported $7.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.22 by $0.29. The Cigna Group had a return on equity of 18.42% and a net margin of 1.31%. The firm had revenue of $63.70 billion for the quarter, compared to analyst estimates of $59.58 billion. During the same period in the previous year, the company posted $6.77 earnings per share. The company’s quarterly revenue was up 29.8% compared to the same quarter last year. On average, equities analysts predict that The Cigna Group will post 28.5 EPS for the current year.
The Cigna Group Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Thursday, December 19th. Investors of record on Wednesday, December 4th will be given a dividend of $1.40 per share. The ex-dividend date of this dividend is Wednesday, December 4th. This represents a $5.60 annualized dividend and a dividend yield of 1.73%. The Cigna Group’s dividend payout ratio (DPR) is presently 52.83%.
Analysts Set New Price Targets
A number of equities research analysts have issued reports on CI shares. Jefferies Financial Group lifted their target price on shares of The Cigna Group from $402.00 to $422.00 and gave the company a “buy” rating in a research note on Tuesday, September 17th. Stephens restated an “overweight” rating and issued a $410.00 target price on shares of The Cigna Group in a research note on Friday, November 1st. StockNews.com downgraded The Cigna Group from a “strong-buy” rating to a “buy” rating in a research note on Monday, November 4th. Cantor Fitzgerald reissued an “overweight” rating and issued a $400.00 price target on shares of The Cigna Group in a research note on Wednesday, October 23rd. Finally, JPMorgan Chase & Co. increased their price objective on The Cigna Group from $435.00 to $438.00 and gave the stock an “overweight” rating in a report on Wednesday, August 21st. One investment analyst has rated the stock with a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and an average price target of $394.64.
About The Cigna Group
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Further Reading
- Five stocks we like better than The Cigna Group
- How to Choose Top Rated Stocks
- 3 Stocks Near 52-Week Lows That Could Be Top Buys Right Now
- The Significance of Brokerage Rankings in Stock Selection
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.